Skip to primary navigation
Skip to main content
Skip to footer
Fractyl Health
Transformative Metabolic Therapies
Investors
Clinical Studies
Careers
Our Focus
Obesity
Type 2 Diabetes
Our Platforms
Revita
Rejuva
Our Science
Clinical Studies
Presentations & Publications
Our Company
Culture
Our Team
Careers
Our News
Media Kit
Home
/
Type 2 diabetes
Ein prospektives Nachmarkt-Klinik-Follow-up-Register zur Bewertung der realen Wirksamkeit und Patientenzufriedenheit nach der Duodenalmukosa-Resurfacing bei Patienten mit Typ-2-Diabetes
Type 2 diabetes
March 21, 2025
by
October 5, 2024
by
Our Focus
Obesity
Type 2 Diabetes
Our Platforms
Revita
Rejuva
Our Science
Clinical Studies
Presentations & Publications
Our Company
Culture
Our Team
Careers
Our News
Media Kit
Investors